1. Abbiati G, Fossati T, Lachmann G, Bergamaschi M, Castiglioni C (1993) Absorption tissue distribution and excretion of radiolabelled compounds in rats after administration of [14C]-L-alpha-glycerylphosphorylcholine. Eur J Drug Metab Pharmacokinet 18:173–180
2. Ayyar VS, Krzyzanski W, Jusko WJ (2019) Indirect pharmacodynamic models for responses with circadian removal. J Pharmacokinet Pharmacodyn 46:89–101
3. Chong Kun Dang Pharmaceutical Corp. Gliatirin Soft Cap. (Choline alfoscerate) [package insert]. Ministry of Food and Drug Safety. https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetail?itemSeq=200600026. Accessed 28 July 2021
4. FDA (2018) Bioanalytical Method Validation Guidance for Industry.Center for Drug Evaluation and Research. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioanalytical-method-validation-guidance-industry.Accessed 22 May 2018
5. FDA (2021) Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA.Center for Drug Evaluation and Research. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/bioequivalence-studies-pharmacokinetic-endpoints-drugs-submitted-under-abbreviated-new-drug. Accessed 20 August 2021